B vitamins and folate chemistry, analysis, function and effects / ed. V.R. Preedy. London: RSC, 2013. 888p.

Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab, 2000, 71(1-2): 121-138.

Cunningham F, Leveno K, Bloom S, et al. Hematological disorders. In: Williams Obstetrics, 23rd ed. New York: McGraw-Hill, 2009.

Pietrzik K, Bailey L, Shane B. Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clin Pharmacok, 2010, 49(8): 535-548.

Шехтман М.М. Руководство по экстра-генитальной патологии у беременных. 5-е изд. М.: Триада-Х, 2011, 896 с.

Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. AdvNutr., 2012, 3(1): 21-38.

Duthie SJ. Folat and cancer: how DNA damage, repair and methylation impact on colon carcino-genesis. J Inherit Metab Dis., 2011, 34: 101-109.

Kidd PM. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Altern Med Rev., 2008, 13: 85-115.

Greenberg JA, Bell SJ, Guan Y, et al. Folic Acid Supplementaion and Pregnancy: More Than Just Neural Tube Defect Prevention. Rev Obstet Gynecol., 2011, 4(2): 52-59.

Lumley J, et al. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database of Systematic Reviews. 2007. Issue 4. Art. No.:CD001056.

Fekete K, Berti C, Trovato M, et al. Effect of folate intake on health outcomes in pregnancy: a systematic review and meta-analysis on birth weight, placental weight and length of gestation. Nutr J., 2012, 11: 75-86.

Prinz-Langenohl R, Bramswig S, Tobolski O, et al. (6S)-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C, T polymorphism of methylenetetrahydro-folate reductase. Br J Pharmacol, 2009, 158: 2014-2021.

Trabetti E. Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk. J Appl Genet., 2008, 49: 267-282.

Xiao Y, Zhang Y, Wang M, et al. Plasma S-adeno sylhomocysteine is associated with the risk of cardiovascular events in patients undergoing coronary angiography: a cohort study. Am J Clin Nutr, 2013, 98: 1162-1169.

Naess IA, Christiansen SC, Romundstad PR, et al. Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population-results from the HUNT 2 study. Br J Haematol., 2008, 141: 529-535.

Refsum H, Nurk E, Smith AD, et al. The Hordaland Homocysteine Study: A Community-Based Study of Homocysteine, Its Determinants, and Associations with Disease. J Nutr, 2006, 136: 1731-1740.

Vollset SE, Refsum H, Tverdal A, et al. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr., 2001, 74: 130-136.

Djuric D, Jakovljevic V, Rasic-Markovic A, et al. Homocysteine, Folic acid and coronary artery disease: possible impact on prognosis and therapy. The indian J Chest Dis., 2008, 50.

Tu JV, Nardi L, Fang J, et al. National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004. CMAJ 2009; 180: E118-25.

Yang Q, Botto LD, Erickson JD, et al. Improvement in stroke mortality in Canada and in England and Wales, 1990 to 2002. Circulation, 2006, 113: 1335-1343.

Clarke R, Halsey J, Lewington S, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med, 2010, 170: 1622-31.

Wang X, Qin X, Demirtas H, Li J, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet, 2007, 369: 1876-82.

Wang X, Wu X, Liang Z, et al. A comparison of folic acid deficiency-induced genomic instability in lymphocytes of breast cancer patients and normal non-cancer controls from a Chinese population in Yunnan. Mutagenesis, 2006, 21(1): 41-47.

Gibson TM, Weinstein SJ, Pfeiffer RM, et al. Pre-and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States. Am J Clin Nutr, 2011.

Piyathilake CJ, Macaluso M, Alvarez RD, et al. Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification era. Cancer Prev Res (Phila), 2009, 2: 658-64.

Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res., 2007, 51(3): 267-292.

Tavani A, Malerba S, Pelucchi C, et aL Dietary Folates and canser risk in a network of case-control studies. Annals of Oncology, 2012, 23: 2737-2742.